Arrow Mark Colorado Holdings LLC Heron Therapeutics, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

$7.03 Billion
Q3 2024

A detailed history of Arrow Mark Colorado Holdings LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 16,100 shares of HRTX stock, worth $19,159. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,100

Previous 16,100 -0.0%

Holding current value

$19,159

Previous $56,000 42.86%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.54 - $1.82 $5,547 - $18,696	-10,273 Reduced 38.95%	16,100 $27,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $3.68 Million - $9.54 Million	-3,310,941 Reduced 99.21%	26,373 $30,000
Q1 2023 May 15, 2023	SELL	$1.51 - $3.25 $337,536 - $726,485	-223,534 Reduced 6.28%	3,337,314 $5.04 Million
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $4.59 Million - $9.53 Million	-2,040,259 Reduced 36.43%	3,560,848 $8.9 Million
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $2.79 Million - $5.63 Million	-1,048,065 Reduced 15.76%	5,601,107 $23.6 Million
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $144,141 - $394,194	62,670 Added 0.95%	6,649,172 $18.6 Million
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $836,349 - $1.8 Million	180,637 Added 2.82%	6,586,502 $37.7 Million
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $129,174 - $194,922	-15,470 Reduced 0.24%	6,405,865 $58.5 Million
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $5.24 Million - $7.76 Million	517,367 Added 8.76%	6,421,335 $68.6 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $3.62 Million - $5.04 Million	272,952 Added 4.85%	5,903,968 $91.6 Million
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $3.9 Million - $5.58 Million	269,405 Added 5.02%	5,631,016 $91.3 Million
Q4 2020 Feb 16, 2021	BUY	$14.61 - $22.14 $4.41 Million - $6.69 Million	302,085 Added 5.97%	5,361,611 $113 Million
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $1.53 Million - $1.99 Million	-111,898 Reduced 2.16%	5,059,526 $75 Million
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $8.02 Million - $15.8 Million	736,637 Added 16.61%	5,171,424 $76.1 Million
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $3.34 Million - $8.01 Million	326,159 Added 7.94%	4,434,787 $52.1 Million
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $1.02 Million - $1.56 Million	-58,622 Reduced 1.41%	4,108,628 $96.6 Million
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $4.27 Million - $5.58 Million	260,888 Added 6.68%	4,167,250 $77.1 Million
Q2 2019 Aug 14, 2019	BUY	$16.93 - $26.22 $21 Million - $32.5 Million	1,237,719 Added 46.38%	3,906,362 $72.6 Million
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $10.3 Million - $12.6 Million	443,593 Added 19.94%	2,668,643 $65.2 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $4.38 Million - $6.37 Million	198,909 Added 9.82%	2,225,050 $57.7 Million
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $5.77 Million - $7.85 Million	-192,235 Reduced 8.67%	2,026,141 $64.1 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $3.95 Million - $6.28 Million	-149,546 Reduced 6.32%	2,218,376 $86.2 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $28.2 Million - $44.1 Million	1,529,805 Added 182.53%	2,367,922 $65.4 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $3.09 Million - $3.93 Million	208,548 Added 33.13%	838,117 $15.2 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $9.22 Million - $10.6 Million	629,569	629,569 $10.2 Million

Others Institutions Holding HRTX

# of Institutions

181

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $141M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account

Arrow Mark Colorado Holdings LLC Heron Therapeutics, Inc. Transaction History